Thrombin-Antithrombin System

作者: Toshiaki Iba

DOI: 10.1007/978-3-030-53606-0_4

关键词:

摘要: Antithrombin (AT) is the most abundant and important physiological anticoagulant in body [1]. AT deficiency animal results embryonic death, mutations that reduce levels result severe thrombotic conditions. For example, AT-deficient fish exhibited consumptive coagulopathy or disseminated intravascular coagulation (DIC) following injury [2]. It generally accepted thrombin produced as a of activation innate immune system after injury, natural anticoagulants play role preventing accidental clot formation. Since ancient times massive blood loss from trauma has been frequent life-threatening event encountered by humans. As result, heavy-duty evolved to promote hemostasis setting injury. In face this thrombogenic tendency, impairment mechanisms can easily induce problematic events critical situations, including [3]. dysregulated over-activation tends occur under such circumstances. The disorder represented microvascular thrombi contribute decreased oxygen delivery subsequent organ dysfunction. Accordingly, therapy expected some alleviating dangerous [4]. Large-scale randomized controlled trials (RCTs) examine effects therapies were conducted early 2000s, predominantly focused on sepsis [5–7], but none agents examined demonstrated clear beneficial effect. no currently approved for clinical use treatment DIC. However, have suggested sepsis-associated DIC, not itself, could benefit therapies. Some subgroup analyses performed among subjects with DIC aforementioned revealed trends toward favorable activated protein C mortality [8, 9]. Recently, small, well-designed RCT succeeded demonstrating efficacy dose obtaining resolution septic patients [10]. addition, recombinant thrombomodulin also shown trend [11]. Analyses using nationwide administrative database Japan positive supplementation [12, 13]. there still concrete evidence trauma-induced (TIC). part chapter, structure, unique characteristics naturally derived anticoagulant, theoretical background systemic disorders are introduced.

参考文章(61)
B. Fan, B.C. Crews, I.V. Turko, J. Choay, G. Zettlmeissl, P. Gettins, Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. Effect of glycosylation differences on heparin binding and structure. Journal of Biological Chemistry. ,vol. 268, pp. 17588- 17596 ,(1993) , 10.1016/S0021-9258(19)85373-5
Rene Moser, Peter Groscurth, Jorg Fehr, Promotion of transendothelial neutrophil passage by human thrombin Journal of Cell Science. ,vol. 96, pp. 737- 744 ,(1990)
Shaun R. Coughlin, Thrombin signalling and protease-activated receptors Nature. ,vol. 407, pp. 258- 264 ,(2000) , 10.1038/35025229
VALERIA S. OSSOVSKAYA, NIGEL W. BUNNETT, Protease-Activated Receptors: Contribution to Physiology and Disease Physiological Reviews. ,vol. 84, pp. 579- 621 ,(2004) , 10.1152/PHYSREV.00028.2003
B. Blauhut, H. Kramar, H. Vinazzer, H. Bergmann, Substitution of antithrombin III in shock and DIC: A randomized study Thrombosis Research. ,vol. 39, pp. 81- 89 ,(1985) , 10.1016/0049-3848(85)90123-9
Steven T. Olson, Ann Marie Frances-Chmura, Rick Swanson, Ingemar Björk, Gerd Zettlmeissl, Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity. Archives of Biochemistry and Biophysics. ,vol. 341, pp. 212- 221 ,(1997) , 10.1006/ABBI.1997.9973
U. Koca, C. Olguner, S. Ozkardesler, A. Karci, C. Coker, P. Tuncel, A. Tasdogen, S. Duru, C. Ulukus, Z. Elar, Antithrombin III pretreatment reduces neutrophil recruitment into the lung in a rat model of abdominal sepsis. Acta Anaesthesiologica Scandinavica. ,vol. 49, pp. 203- 208 ,(2005) , 10.1111/J.1399-6576.2004.00567.X
Louise Garone, Tim Edmunds, Eric Hanson, Richard Bernasconi, James A. Huntington, Jennifer L. Meagher, Bingqi Fan, Peter G. W. Gettins, Antithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155. Biochemistry. ,vol. 35, pp. 8881- 8889 ,(1996) , 10.1021/BI960542M
John T. Owings, Margaret Bagley, Robert Gosselin, Diane Romac, Elizabeth Disbrow, Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. Journal of Trauma-injury Infection and Critical Care. ,vol. 41, pp. 396- 406 ,(1996) , 10.1097/00005373-199609000-00004